Castle Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Revenue	219.79	137.04	94.09	62.65	51.87	22.79	13.75
Revenue Growth (YoY)	60.38%	45.65%	50.18%	20.79%	127.62%	65.67%	-
Cost of Revenue	44.98	32.01	15.82	9.69	7.31	5.3	4.92
Gross Profit	174.81	105.03	78.26	52.96	44.56	17.49	8.83
Selling, General & Admin	180.15	143	86.74	48.13	29.84	16.47	15.26
Research & Development	53.62	44.9	29.65	13.26	7.39	4.85	4.47
Other Operating Expenses	9.01	8.27	1.96	-1.88	0	0	0
Operating Expenses	242.78	196.17	118.34	59.51	37.23	21.33	19.73
Operating Income	-67.98	-91.14	-40.08	-6.54	7.33	-3.84	-10.9
Interest Expense / Income	0.01	0.02	0	2.63	4.57	2.27	1.65
Other Expense / Income	-10.62	-22.26	-0.07	1.02	-2.59	0.25	-0.19
Pretax Income	-57.37	-68.9	-40.01	-10.2	5.35	-6.36	-12.36
Income Tax	0.1	-1.77	-8.72	0.08	0.07	0.01	0.01
Net Income	-57.47	-67.14	-31.29	-10.28	5.28	-6.37	-12.37
Preferred Dividends	0	0	0	0	2.29	3.8	2.94
Net Income Common	-57.47	-67.14	-31.29	-10.28	2.99	-10.16	-15.31
Shares Outstanding (Basic)	27	26	25	19	9	2	2
Shares Outstanding (Diluted)	27	26	25	19	9	2	2
Shares Change	2.87%	3.65%	32.80%	118.63%	354.25%	0.55%	-
EPS (Basic)	-2.14	-2.58	-1.24	-0.54	0.35	-5.33	-8.08
EPS (Diluted)	-2.14	-2.58	-1.24	-0.54	-0.21	-5.33	-8.08
Free Cash Flow	-19.23	-47.09	-22.46	5.12	6.08	-12.57	-12.73
Free Cash Flow Per Share	-0.72	-1.81	-0.89	0.27	0.71	-6.60	-6.71
Gross Margin	79.53%	76.64%	83.18%	84.54%	85.91%	76.75%	64.21%
Operating Margin	-30.93%	-66.51%	-42.60%	-10.44%	14.13%	-16.83%	-79.25%
Profit Margin	-26.15%	-48.99%	-33.26%	-16.42%	5.77%	-44.60%	-111.30%
Free Cash Flow Margin	-8.75%	-34.36%	-23.87%	8.17%	11.72%	-55.17%	-92.54%
Effective Tax Rate	-	-	-	-	1.35%	-	-
EBITDA	-45.02	-58.34	-36.6	-7.09	10.28	-3.76	-10.4
EBITDA Margin	-20.49%	-42.57%	-38.91%	-11.32%	19.82%	-16.51%	-75.61%
Depreciation & Amortization	12.33	10.54	3.41	0.47	0.36	0.32	0.31
EBIT	-57.35	-68.89	-40.01	-7.57	9.92	-4.08	-10.71
EBIT Margin	-26.10%	-50.27%	-42.53%	-12.08%	19.13%	-17.92%	-77.87%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).